Vanderbilt University Medical Center: Cardiovascular Diseases trials
The registry lists 12 Cardiovascular Diseases studies with Vanderbilt University Medical Center as lead sponsor. 4 are open to participants now and 3 have results posted.
Early Phase 1 1Phase 2 2No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIVRecruitingNCT07221214Phase 2
- Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCTRecruitingNCT05288790Phase 2
- Gut Microbiota in Metabolic SurgeryRecruitingNCT05000996
- Autoimmune Basis for Postural Tachycardia SyndromeEnrolling by invitationNCT02725060Not applicable
- Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular DiseaseTerminatedNCT03709771Results posted
- Oatmeal Effect on N-acyl-phosphatidylethanolaminesCompletedNCT03468179Not applicableResults posted
- Mechanisms of Chronic Kidney Disease (CKD)-Induced Foam Cell FormationCompletedNCT01671605Results posted
- Home-Based Cardiac Rehabilitation for Patients With Heart FailureActive, not recruitingNCT06479876Not applicable
- RESIPI for Reducing Perioperative Major Adverse Cardiac EventsTerminatedNCT03208023Not applicable
- Modafinil and Cognitive Function in POTSActive, not recruitingNCT01988883Early Phase 1
- Medications and the Risk of Sudden Cardiac DeathCompletedNCT00241800
- Soy Food and Coronary Heart Disease in WomenCompletedNCT00241735